mrna moderna - Search News

FDA refuses review of mRNA flu vaccine

FDA Refuses To Review Moderna mRNA Flu Vaccine and the US Could Miss Out on Next Generation Fu Shots

In a rare and surprising move, the FDA has issued a “Refusal to File” letter for Moderna’s mRNA-1010 influenza vaccine. Moderna is a batch company that has now become a household name for helping to fight a global pandemic.

· 3d

FDA refuses to review Moderna's mRNA flu shot

· 5d

Moderna says FDA refuses its application for new mRNA flu vaccine

Moderna: FDA RTF Derails mRNA-1010 And Reignites The Sell Case

Moderna stock is rated Sell amid FDA setbacks for mRNA-1010, commoditized COVID/RSV sales, and cash burn. Read the analysis ...

Just The News

Moderna threatens American jobs after FDA snubs mRNA flu shot, trial looked 'scientifically lax'

Drug observers puzzled by vaccine maker, which made a killing on COVID-19, failing to read the room with new administration. Moderna puts heat on FDA vaccines chief who's already been rebuked once by ...

Blockonomi

Moderna (MRNA) Stock Slips Despite Beating Q4 Revenue and Earnings Estimates

Moderna (MRNA) stock fell 0.3% Friday despite beating Q4 revenue estimates at $678M and posting narrower loss of $2.11/share after FDA rejected flu vaccine review.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results